These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26475973)

  • 41. Management of orbital invasion in sinonasal malignancies.
    Lisan Q; Kolb F; Temam S; Tao Y; Janot F; Moya-Plana A
    Head Neck; 2016 Nov; 38(11):1650-1656. PubMed ID: 27131342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Surgical management of orbital malignant melanoma: our experience and a report of three cases].
    Poli T; Mora P; Reichegger V; Ricci R; Corradi D; Gandolfi SA; Sesenna E
    Klin Monbl Augenheilkd; 2007 Oct; 224(10):794-8. PubMed ID: 17952825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Does orbital exenteration still has a place in 2019?].
    Martel A; Hamedani M; Lagier J; Bertolotto C; Gastaud L; Poissonnet G
    J Fr Ophtalmol; 2020 Feb; 43(2):152-174. PubMed ID: 31831277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of induction chemotherapy for orbital invasion in sinonasal malignancies: A systematic review.
    Tang A; Calcaterra M; Harris M; Gardner PA; Zenonos GA; Stefko ST; Geltzeiler M; Zandberg DP; Snyderman CH; Wang EW; Choby G
    Int Forum Allergy Rhinol; 2024 Jul; 14(7):1226-1239. PubMed ID: 38829173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid Rehabilitation With Skin-Muscle Sparing Orbital Exenteration: A Single-Center Series.
    Jayaprakasam A; Vahdani K; Rose GE; Saleh GM; Hussain B; Verity DH; Collin JRO
    Ophthalmic Plast Reconstr Surg; 2021 Jan-Feb 01; 37(1):51-54. PubMed ID: 32379171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experience with eyelid-sparing orbital exenteration: the 2000 Tullos O. Coston Lecture.
    Shields JA; Shields CL; Demirci H; Honavar SG; Singh AD
    Ophthalmic Plast Reconstr Surg; 2001 Sep; 17(5):355-61. PubMed ID: 11642492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Orbital exenteration in elderly patients: personal experience.
    Croce A; Moretti A; D'Agostino L; Zingariello P
    Acta Otorhinolaryngol Ital; 2008 Aug; 28(4):193-9. PubMed ID: 18939708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Orbital Exenteration for Advanced Periocular Adnexal Malignancies: Curative Versus Palliative Surgical Intent.
    Malik M; Vahdani K; Rose GE; Daniel C; Uddin JM; Verity DH; Collin JRO
    Ophthalmic Plast Reconstr Surg; 2022 Jul-Aug 01; 38(4):387-392. PubMed ID: 35093991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inverted papillomas of the nasal and paranasal sinuses that involve the ocular/adnexal region.
    Saldana M; Wearne M; Beigi B; Petrarca R
    Orbit; 2013 Dec; 32(6):366-9. PubMed ID: 24063373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors related to survival outcomes following orbital exenteration: a retrospective, comparative, case series.
    Aryasit O; Preechawai P; Hirunpat C; Horatanaruang O; Singha P
    BMC Ophthalmol; 2018 Jul; 18(1):186. PubMed ID: 30055580
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anterior retrograde approach to the myofascial temporalis muscle for orbital reconstruction: series of 9 consecutive cases.
    Torroni A; Cervelli D; Gasparini G; Grussu F; Moro A; Marianetti TM; Foresta E; Azzuni C; Pelo S
    Ann Plast Surg; 2015 Jan; 74(1):37-42. PubMed ID: 23872965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Orbital preservation in surgical management of sinonasal malignancy.
    Imola MJ; Schramm VL
    Laryngoscope; 2002 Aug; 112(8 Pt 1):1357-65. PubMed ID: 12172245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Survival after malignant tumors of the orbit and periorbit treated by exenteration.
    Mouriaux F; Martinot V; Pellerin P; Patenotre P; Rouland JF; Constantinides G
    Acta Ophthalmol Scand; 1999 Jun; 77(3):326-30. PubMed ID: 10406155
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patterns and incidence of sinonasal malignancy with orbital invasion.
    Chu Y; Liu HG; Yu ZK
    Chin Med J (Engl); 2012 May; 125(9):1638-42. PubMed ID: 22800835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How can we decide on orbital exenteration for second eye in a patient with basal cell carcinoma?
    Copcu E; Sivrioglu N; Baytekin C; Er S; Koc B
    Plast Reconstr Surg; 2006 Jun; 117(7):2512-4. PubMed ID: 16772980
    [No Abstract]   [Full Text] [Related]  

  • 56. Cutaneous nasal malignancies: is primary reconstruction safe?
    Evans GR; Williams JZ; Ainslie NB
    Head Neck; 1997 May; 19(3):182-7. PubMed ID: 9142516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of Metastatic Eyelid Carcinoma.
    Bonavolontà P; Dell'Aversana Orabona G; Abbate V; Iaconetta G; Bonavolontà G; Califano L
    J Craniofac Surg; 2017 Nov; 28(8):e722-e725. PubMed ID: 28885435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonmelanoma facial skin carcinomas: methods of treatment.
    Kiliç C; Tuncel U; Comert E; Polat I
    J Craniofac Surg; 2014; 25(2):e113-6. PubMed ID: 24621749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinicodemographic profile of orbital exenteration in a tertiary eye care center - A 20-year experience.
    Meel R; Pushker N; Kashyap S; Chaurasia S; Rathod A; Bajaj MS; Sen S; Agrawal S
    Indian J Ophthalmol; 2024 Jul; 72(Suppl 4):S610-S615. PubMed ID: 38454866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quality of life factors and survival after total or extended maxillectomy for sinonasal malignancies.
    Murphy J; Isaiah A; Wolf JS; Lubek JE
    J Oral Maxillofac Surg; 2015 Apr; 73(4):759-63. PubMed ID: 25661508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.